Industry Information

In the ever – evolving world of pharmaceuticals, GLP – 1 drugs have emerged as a revolutionary class of medications, and Vetino Pharma is at the forefront of this innovation with its high – quality generic versions. Our portfolio, which includes Oral Semaglutide Tablets, Semaglutide Injection, and Tirzepatide Injection, can be explored in detail at our product page. […]

Market data reveals Tirzepatide captured ‌35% of the GLP-1 agonist market‌ within 18 months of launch, while semaglutide growth slowed to 12%. This seismic shift stems from three revolutionary advantages: 1. Dual-Target Mechanism: Superior Metabolic Control‌ Molecular Advantage‌ Drug Target Pathway Activation Semaglutide GLP-1 monoagonist Single-pathway stimulation Tirzepatide GIP/GLP-1 dual agonist Synchronized glucose-insulin regulation Clinical